Direct evidence for the interaction of neurokinin A with the tachykinin NK 1 receptor in tissue

By Bremer A.A.   Tansky M.F.   Wu M.   Boyd N.D.   Leeman S.E.  

European Journal of Pharmacology, Vol. 423, Iss. 2, 2001-07 ,pp. : 143-147

Elsevier

Access to resources Recommend Favorite

SCH 206272: a potent, orally active tachykinin NK 1 , NK 2 , and NK 3 receptor antagonist

By Anthes J.C.   Chapman R.W.   Richard C.   Eckel S.   Corboz M.   Hey J.A.   Fernandez X.   Greenfeder S.   McLeod R.   Sehring S.   Rizzo C.   Crawley Y.   Shih N.-Y.   Piwinski J.   Reichard G.   Ting P.   Carruthers N.   Cuss F.M.   Billah M.   Kreutner W.   Egan R.W.  

European Journal of Pharmacology, Vol. 450, Iss. 2, 2002-08 ,pp. : 191-202

Elsevier

Access to resources Recommend Favorite

In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK 1 and NK 2 receptor antagonist

By Robineau P.   Lonchampt M.   Kucharczyk N.   Krause J.E.   Regoli D.   Fauchere J.-L.   Prost J.-F.   Canet E.  

European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. : 677-684

Elsevier

Access to resources Recommend Favorite

In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [ 3 H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine)

By Anderson J.J.   Bradbury M.J.   Giracello D.R.   Chapman D.F.   Holtz G.   Roppe J.   King C.   Cosford N.D.P.   Varney M.A.  

European Journal of Pharmacology, Vol. 473, Iss. 1, 2003-07 ,pp. : 35-40

Elsevier

Access to resources Recommend Favorite

An investigation of tachykinin NK 2 receptor subtypes in the rat

By Matuszek M.A.   Zeng X.-P.   Strigas J.   Burcher E.  

European Journal of Pharmacology, Vol. 352, Iss. 1, 1998-07 ,pp. : 103-109

Elsevier

Access to resources Recommend Favorite